Haukeland University Hospital
Bergen, Norway
34 recruiting
Showing 1–20 of 34 trials
Recruiting
Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
Phase 3
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
Acute Myeloid Leukemia
University of Ulm650 enrolled91 locationsNCT04628026
Recruiting
Phase 3
Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
High-risk Melanoma
Uppsala University1,792 enrolled26 locationsNCT06488482
Recruiting
Phase 3
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Advanced Melanoma
Immunocore Ltd680 enrolled211 locationsNCT06112314
Recruiting
Phase 4
Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)
Rheumatoid Arthritis
Diakonhjemmet Hospital350 enrolled22 locationsNCT06440629
Recruiting
Phase 2
Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.
Soft Tissue Sarcoma (STS)Soft Tissue Sarcoma AdultSynovial Sarcomas+7 more
Oslo University Hospital40 enrolled2 locationsNCT07173972
Recruiting
Phase 2
Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma
Soft Tissue Sarcoma AdultLeiomyosarcomaSynovial Sarcomas+6 more
Oslo University Hospital110 enrolled4 locationsNCT07169344
Recruiting
Not Applicable
RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3
Radiotherapy Side EffectHead and Neck Cancer
Oslo University Hospital100 enrolled3 locationsNCT06297902
Recruiting
Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company535 enrolled84 locationsNCT05614739
Recruiting
Phase 3
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Acute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia
Princess Maxima Center for Pediatric Oncology160 enrolled112 locationsNCT05327894
Recruiting
Phase 2
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Parkinson's DiseaseParkinson Disease (PD)
Haukeland University Hospital100 enrolled11 locationsNCT07312110
Recruiting
Not Applicable
Exercise Therapy in Mental Disorders-study
Bipolar DisorderSchizophrenia and Related Disorders
Haukeland University Hospital50 enrolled1 locationNCT06313918
Recruiting
The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract
Upper Urinary Tract Urothelial Carcinoma
Zealand University Hospital2,500 enrolled5 locationsNCT07077447
Recruiting
Phase 4
Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
Non Muscle Invasive Bladder Cancer
Jakob Kristian Jakobsen272 enrolled8 locationsNCT06781879
Recruiting
Cerebellar Mutism Syndrome Study
Infratentorial NeoplasmsMutism
Rigshospitalet, Denmark1,000 enrolled30 locationsNCT02300766
Recruiting
Not Applicable
Patient-centered Dosage of Levothyroxine
Thyroid CancerThyroidHypothyroidism
University Hospital of North Norway240 enrolled3 locationsNCT06455371
Recruiting
Phase 2
Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma
Soft Tissue Sarcoma
Oslo University Hospital49 enrolled2 locationsNCT04776525
Recruiting
Phase 3
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
High Risk NeuroblastomaPatient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris800 enrolled142 locationsNCT04221035
Recruiting
Phase 1Phase 2
A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients
Acute Myeloid Leukemia, AdultMyelodysplastic Syndromes, Adult
Haukeland University Hospital48 enrolled1 locationNCT06199557
Recruiting
Phase 4
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing
AsthmaInflammation
St. Olavs Hospital280 enrolled8 locationsNCT03889743